All Stories

  1. The effect of the COVID-19 pandemic on severe asthma care in Europe - will care change for good?

    Article • ERJ Open Research, April 2022, European Respiratory Society (ERS)

    Katrien Eger, Dr Valentyna Yasinska

  2. Real world residual disease manifestations after 2-years anti-IL-5 treatment for severe asthma

    Article • September 2020, European Respiratory Society (ERS)

    Katrien Eger

  3. Late Breaking Abstract - Overuse of oral corticosteroids in asthma – modifiable factors and potential role of biologics

    Article • September 2019, European Respiratory Society (ERS)

    Katrien Eger